Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01093 CSPC PHARMA
RTNominal up6.600 +0.080 (+1.227%)
Result Announcements

26/08/2020 12:21

CSPC Pharma (01093) interim net up 23% to RMB2.31bn


[ET Net News Agency, 26 August 2020] CSPC Pharmaceutical Group Limited (01093) said its
profit attributable to shareholders was RMB2.31 billion for the six months ended 30 June
2020, a year-on-year increase of 23.2%. The basic earnings per share were RMB30.97 cents.
An interim dividend of HK6 cents will be distributed. The board has also proposed a bonus
issue of three new shares for every five existing shares held by shareholders of the
company.
The total revenue was RMB12.59 billion, a year-on-year increase of 12.6%. (RC)

Back to Result Announcements

Remark: Real time quote last updated: 26/04/2024 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.